- Home
- IMNM vs RES Comparison
IMNM vs RES Comparison
Compare IMNM & RES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- RES
- Stock Information
- Founded
- IMNM 2006
- RES 1984
- Country
- IMNM United States
- RES United States
- Employees
- IMNM N/A
- RES N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- RES Oilfield Services/Equipment
- Sector
- IMNM Health Care
- RES Energy
- Exchange
- IMNM Nasdaq
- RES Nasdaq
- Market Cap
- IMNM 945.8M
- RES 1.0B
- IPO Year
- IMNM 2020
- RES N/A
- Fundamental
- Price
- IMNM $9.01
- RES $4.57
- Analyst Decision
- IMNM Strong Buy
- RES Hold
- Analyst Count
- IMNM 8
- RES 4
- Target Price
- IMNM $24.75
- RES $4.69
- AVG Volume (30 Days)
- IMNM 1.0M
- RES 1.3M
- Earning Date
- IMNM 11-12-2025
- RES 10-23-2025
- Dividend Yield
- IMNM N/A
- RES 3.49%
- EPS Growth
- IMNM N/A
- RES N/A
- EPS
- IMNM N/A
- RES 0.25
- Revenue
- IMNM $12,589,000.00
- RES $1,426,699,000.00
- Revenue This Year
- IMNM N/A
- RES $11.80
- Revenue Next Year
- IMNM $154.73
- RES $6.13
- P/E Ratio
- IMNM N/A
- RES $18.33
- Revenue Growth
- IMNM 16.74
- RES N/A
- 52 Week Low
- IMNM $5.15
- RES $4.10
- 52 Week High
- IMNM $16.73
- RES $7.22
- Technical
- Relative Strength Index (RSI)
- IMNM 43.25
- RES 47.38
- Support Level
- IMNM $9.01
- RES $4.46
- Resistance Level
- IMNM $9.63
- RES $4.71
- Average True Range (ATR)
- IMNM 0.71
- RES 0.16
- MACD
- IMNM -0.07
- RES -0.01
- Stochastic Oscillator
- IMNM 17.38
- RES 31.08
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About RES RPC Inc.
RPC Inc is an oilfield services company. It provides specialized oilfield services and equipment to independent and oil and gas companies engaged in the exploration, production, and development of oil and gas properties throughout the United States. The company's operating segment includes Technical Services and Support Services. It generates maximum revenue from the Technical Services segment. Technical Services segment nclude RPC's oil and gas services that utilize people and equipment to perform value-added completion, production and maintenance services directly to a customer's well. Support Services segment consists of drill pipe and related tools, pipe handling, pipe inspection and storage services, and oilfield training and consulting services.